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Abstract Many countries, like Denmark, have tailored
Disease Management Programs (DMPs) based on patients
having single chronic diseases [defined institutionally as
‘‘program diseases’’ (PDs)], which can complicate treat-
ment for those with multiple chronic diseases. The aims of
this study were (a) to assess the prevalence and overlap
among acutely hospitalized older medical patients of PDs
defined by the DMPs, and (b) to examine transitions
between different departments during hospitalization and
mortality and readmission within two time intervals among
patients with the different PDs. We conducted a registry
study of 4649 acutely hospitalized medical patients
C65 years admitted to Copenhagen University Hospital,
Hvidovre, Denmark, in 2012, and divided patients into six
PD groups (type 2 diabetes, chronic obstructive pulmonary
disease, cardiovascular disease, musculoskeletal disease,
dementia and cancer), each defined by several ICD-10
codes predefined in the DMPs. Of these patients, 904
(19.4%) had 2 ? PDs, and there were 47 different com-
binations of the six different PDs. The most prevalent pair
of PDs was type 2 diabetes with cardiovascular disease in
203 (22.5%) patients, of whom 40.4% had an additional
PD. The range of the cumulative incidence of being read-
mitted within 90 days was between 28.8% for patients
without a PD and 46.6% for patients with more than one
PD. PDs overlapped in many combinations, and all patients
had a high probability of being readmitted. Hence, devel-
oping strategies to create a new generation of DMPs
applicable to older patients with comorbidities could help
clinicians organize treatment across DMPs.
Keywords Disease management program  Older
hospitalized patients  Multimorbidity
Introduction
The prevalence of chronic diseases increases with age (van
den Akker et al. 1998; Fortin et al. 2005; Denton and
Spencer 2010) and systematic reviews have found a
prevalence of multimorbidity (multiple chronic diseases) of
up to 98% in persons aged 60 or older (Marengoni et al.
2011; Fortin et al. 2012). The high number of people with
multimorbidity puts pressure on the existing hospital sys-
tem, which in Denmark as in many other countries is
organized into specialized wards according to organ sys-
tems. Patients with diseases in more than one organ system
risk incoherent trajectories in association with the hospi-
talization because the coordination among different
departments and different parts of the health service may
be perceived as problematic (Boyd et al. 2007; Boult and
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Wieland 2010). Thus, prioritizing collaboration and com-
munication around patients with chronic conditions is
important.
To improve management of chronic diseases, the Danish
Health and Medicines Authority has recommended Disease
Management Programs (DMPs) tailored to Danish health
care (Danish Health and Medicines Authority 2012a),
similar to several other countries (Lugtenberg et al. 2011).
The DMPs are standardized descriptions of the multidis-
ciplinary, multisectional, coordinated and evidence-based
healthcare work. This work includes prevention, diagnosis,
treatment, rehabilitation and follow-up, cooperation and
coordination between the acute and primary care settings
based on a specific patient group (Danish Health and
Medicines Authority 2012a).
The DMPs address single diseases which are in accor-
dance with the focus on treatment of single diseases in
medicine (Tinetti and Fried 2004). Greater attention to
multiple chronic diseases (multimorbidity) (Boyd and
Fortin 2011) is warranted, and several countries have
included multimorbidity in their DMPs (Vitry and Zhang
2008; Lugtenberg et al. 2011). Multimorbidity is often
discussed in general without concrete actions (Lugtenberg
et al. 2011), and the evidence for treatment and rehabili-
tation still relies on a single disease concept (Danish Health
and Medicines Authority 2012a). Most studies are designed
for examining single conditions, and individuals with
multimorbidity are therefore often excluded (Starfield
2001; Fortin et al. 2006). International studies problematize
the DMPs’ single disease focus when treating patients with
multimorbidity, stating that DMPs provide limited guid-
ance on the combined use of treatments (Tinetti and Fried
2004; Vitry and Zhang 2008; Boult and Wieland 2010;
Boyd and Fortin 2011; Lugtenberg et al. 2011; Cox et al.
2011; Mutasingwa et al. 2011; Hughes et al. 2013). Several
professional societies and researchers around the world
have started developing guidelines or DMPs for older
patients with multimorbidity (Fabbri et al. 2012; Uhlig
et al. 2014; Weiss et al. 2014; Bernabeu-Wittel et al. 2014),
but the complexity of the different treatment regimens and
the interactions between the DMPs makes the work diffi-
cult. More knowledge is needed about how the patients’
different chronic diseases occur together and the trajecto-
ries for these patients.
In Denmark, DMPs have primarily been implemented in
the primary care setting and in outpatient clinics. Improv-
ing patient care requires implementing coordinated health
care across all sectors to increase our understanding of
complex medical patients and their management. As it is
today, however, hospitals are organized in specialized
wards based on single diseases. Therefore, it is important to
investigate the extent of multimorbidity (based on DMPs)
in the hospital setting and explore the trajectories of these
patients. The aims of this study thus were (a) to study the
prevalence and overlap of program diseases (PDs) defined
by the DMPs among acutely hospitalized older medical
patients, and (b) to examine transitions among different
departments during hospitalization and mortality and
readmission within two time intervals in patients with
different PDs.
Design and methods
Setting
In Denmark, the publicly funded healthcare system covers
all primary and specialist services uniformly for all citi-
zens. Amager and Hvidovre Hospital, University of
Copenhagen, covers 10 municipalities with approximately
460,000 citizens and has approximately 14,000 medical
admissions each year. Of these, 85% are acute. The
emergency department (ED) at Amager and Hvidovre
Hospital consists of a traditional ED and a medical unit,
where patients referred by general practitioners or by
ambulance due to an emergency call can be hospitalized
for up to 3 days before discharge or transfer to a special-
ized medical ward. All Danish citizens have a unique
personal identification number, the Central Personal
Register number (CPR number) (Pedersen 2011). Because
of the CPR number, linkage at the individual level among
nationwide and local registries is feasible.
Study population
Because of the large number of patients hospitalized
acutely, the study population included all medical patients
with a Danish CPR number, aged C 65 years old, who
were acutely admitted to the medical unit at the ED at
Amager and Hvidovre Hospital from January 1, 2012, to
December 31, 2012. Patients were divided into eight
groups: one group with no PD, six groups of patients,
respectively, having only one of the six PDs [type 2 dia-
betes, chronic obstructive pulmonary disease (COPD),
cardiovascular or musculoskeletal disease, dementia or
cancer], and a group of patients with two or more PDs.
Data collection
Data were collected from the Danish National Patient
Registry, a nationwide population registry in Denmark
(Lynge et al. 2011), from the Danish Civil Registration
System (Pedersen 2011), and from the local registry of
Amager and Hvidovre Hospital, University of Copenhagen.
The World Health Organization’s updated International
Classification of Diseases 10th edition (ICD-10)
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classification system was used to define PDs. The system is
divided into 21 chapters representing different organ sys-
tems and categories of health problems (World Health
Organization 2014).
Outcomes
PD: A PD is predefined by the Danish Health and
Medicines Authority by the presence of at least one of the
following ICD-10 codes: type 2 diabetes (E10–E14),
COPD (J44), cardiovascular disease (I20–I21, I25.1 and
I50), musculoskeletal (G550–G553, G558, L88, L71, L97,
M431, M471, M472, M478E, M480, M482, M485B,
M510–M514, M511F, M533, M533B, M539, M543–M545
and S336A), dementia (G30.0, G30.1, G30.8, G31.0B,
G31.8, G31.8E, G31.9, I69.4 and I69.3) and cancer (C00–
C99) according to the Danish DMPs (Capital Region,
Denmark 2009a, b, 2011, 2012a, b; Danish Health and
Medicines Authority 2012b). ICD-10 codes were extracted
from the Danish National Patient Registry based on both
the patient’s first acute hospital admission in 2012 and a
10-year prevalence of the ICD-10 codes registered prior to
the index admission based on recommendations in Schram
et al. (2008).
Transitions during hospitalization: Information regard-
ing the patients’ hospital departments during hospitaliza-
tion was recorded from the local registry of Amager and
Hvidovre Hospital, based on data from the first acute
hospital admission in 2012. One transition was defined as a
transition from the medical unit at the ED to a specialized
ward, and two or more transitions were defined as a tran-
sition from the medical unit at the ED to a specialized ward
and an additional transition to another specialized ward.
Mortality
Time of death was recorded from the Danish Civil Regis-
tration System and from admission and discharge dates
from the Danish National Patient Register. Time to death
was recorded in three different time intervals: during hos-
pitalization, to reflect the quality of care during hospital-
ization; 7 days after admission, to reflect the quality of care
and the discharge process; and 90 days after discharge, to
reflect the patients’ general health.
Readmissions
Admission and discharge dates were recorded from the
Danish National Patient Register. To avoid overestimating
the number of readmissions, a hospital readmission was
defined as an acute admission more than 4 h after dis-
charge. Both acute readmission dates up to 7 and 90 days
after discharge were obtained from the register. An interval
of 7 days was chosen to reflect the quality of care in the
previous hospitalization and discharge process, and
90 days was chosen to reflect the patients’ general health.
Descriptive data
From the Danish Civil Registration System, data were
collected on age and sex. From the Danish National Patient
Register, data were collected on ICD-10 diagnosis codes
(acute and chronic) registered for the first acute hospital
admission in 2012; on length of stay (LOS), based on data
from the first acute hospital admission in 2012; on ICD-10
disease categories, which were categorized according to 17
of the 21 ICD-10 chapters (ICD-10 chapters XV ‘‘Preg-
nancy, childbirth and the puerperium,’’ XVI ‘‘Certain
conditions originating in the perinatal period,’’ XVII
‘‘Congenital malformations, deformations and chromoso-
mal abnormalities,’’ and XIX ‘‘Injury, poisoning and cer-
tain other consequences of external causes,’’ were not
included because of the lack of relevance); and on acute
hospitalization within 6 months prior to the index admis-
sion to reflect patients’ general health.
The study was approved by the Danish Data Protection
Agency (FSEID-00000882). No approval from the
National Committee on Health Research Ethics was needed
because only registries were used.
Statistical analysis
Data are presented as numbers and percentages or as
medians with a corresponding interquartile range (IQR). To
examine for differences between patients with 2 ? PDs
and the other groups, we used a multinomial logistic
regression model for the following variables: age (adjusted
for sex), sex (adjusted for age), ICD-10 disease categories
(adjusted for age and sex), and acute hospitalization within
6 months (adjusted for age and sex). All analyses were
carried out to estimate odds ratios (ORs) with 99% confi-
dence intervals (CIs). The Kruskal–Wallis test was used to
test for differences between patients with 2 ? PDs and the
other groups regarding LOS. A multinomial logistic
regression model (adjusted for age and sex) was also used
to examine whether PDs were associated with transitions
between different departments during hospitalization.
A Cox proportional hazards model was used to test for
the difference between patients with 2 ? PDs and the other
groups in time to readmission (within 7 days and at
90 days after discharge) and to test for the difference in
time to death (during hospitalization, within 7 days after
admission and at 90 days after discharge); the analyses
were adjusted for age, sex, and acute hospitalization within
the last 6 months. A cumulative incidence function was
used to plot time to death, and a cumulative incidence
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function with death as competing event was used to plot
time to readmission for the PDs.
The statistical analyses were conducted using the SAS
9.3 software package for Windows. Plots were created in R
version 3.1.0. The level of significance was set at 0.01 to
account for multiple testing, and all statistical tests were
two-tailed.
Results
In 2012, a total of 4649 patients were admitted acutely to
the medical unit at the ED at Amager and Hvidovre
Hospital, and their characteristics are shown in Table 1. Of
these patients, 904 (19.4%) had 2 ? PDs, 1795 (38.6%)
had one PD, and 1950 (41.9%) patients did not have a PD.
Moreover, in comparing patients with 2 ? PDs with the
other groups, multinomial regression models showed that
patients with the type 2 diabetes PD (OR 0.98, CI99%
0.96–1.00) were younger than patients with 2 ? PDs and
patients with the dementia PD were older than patients with
2 ? PDs (OR 1.06, CI99% 1.04–1.08). There were more
men in the 2 ? PD group than among patients with the
COPD PD (OR 1.57, CI99% 1.16–2.13) and more women in
the 2 ? PD group than among patients with the cardio-
vascular PD (OR 1.80, CI99% 1.27–2.55). Overall, the LOS
was short, with a median between one and 2 days for all
groups except the cancer PD, which had a median LOS of
4 days. Patients with 2 ? PD had a higher LOS than
patients with no PD (p = 0.001) and patients with the
cardiovascular PD (p = 0.008), but a shorter LOS than
patients with the cancer PD (p = 0.001). The risk of being
registered with three or more ICD-10 disease categories
was significantly higher for patients with one or 2 ? PDs
compared with patients not having a PD. Patients with
2 ? PDs had a higher risk of having been acutely hospi-
talized within the last 6 months prior to the index admis-
sion than patients with no PD (OR 3.60, CI99% 2.88–4.52),
type 2 diabetes PD (OR 2.23, CI99% 1.57–3.17), COPD PD
(OR 1.78, CI99% 1.32–2.41), cardiovascular PD (OR 2.64,
CI99% 1.82–3.38), musculoskeletal PD (OR 1.99, CI99%
1.16–3.43) and dementia PD (OR 1.46, CI99% 1.02–2.08).
There were 47 different combinations of overlap of PDs
with frequencies between 0.1 and 13.4% among the 904
patients with 2 ? PDs. Figure 1 shows the proportion of
patients having 2 ? PDs within each of the PDs. The
highest proportion was found for the musculoskeletal PD,
with 60.9% of the 297 patients having 2 ? PDs, and the
lowest proportion was found for the cancer PD, with 47.2%
of 449 patients having 2 ? PDs. The four most prevalent
pairs of PDs among the 904 patients who had more than
one PD are shown in Table 2. The most prevalent pair was
the type 2 diabetes with the cardiovascular PD, with 203
(22.5%) patients, and 40.4% of those patients had an
additional PD.
A total of 2511 (54.0%) patients were discharged
directly from the medical unit at the ED, 1733 (37.3%)
patients experienced one transition from the medical unit at
the ED to a specialized medical department, and 405
(8.7%) patients experienced 2 ? transitions between
departments (Table 3). Patients belonging to the COPD PD
group had a higher risk of being transferred two or more
times during hospitalization than patients with 2 ? PD
(OR 1.99, CI99% 1.19–3.33).
In total, 310 (6.7%) patients died during hospitalization
(Table 3). When comparing patients with 2 ? PDs with
the other groups, patients with no PD had a lower risk of
dying (hazard ratio (HR) 0.64, CI99% 0.43–0.95), and
patients with the cancer PD had a higher risk (HR 1.76,
CI99% 1.11–2.78). The all-cause mortality within 7 days
from admission was higher only for patients with the
cancer PD (HR 2.29, CI99% 1.23–4.24) compared to
patients with 2 ? PDs (Fig. 2a).
Of the 4339 patients who survived the hospitalization,
499 (11.5%) died within 90 days after discharge (Table 3).
The difference between the PDs is depicted in Fig. 2b.
When comparing patients with 2 ? PDs with the other
groups, patients with no PD (HR 0.62 CI99% 0.45–0.86)
and patients with the COPD PD (HR 0.62, CI99%
0.39–1.00) had a lower risk of dying, and patients with the
cancer PD had a higher risk (HR 2.51, CI99% 1.67–3.78).
In total, 423 out of 4339 (9.7%) patients were readmitted
within 7 days from discharge of the patients who survived
the hospitalization (Table 3). The adjusted Cox regression
model showed no difference between patients with 2 ? PD
and any of the other groups. The cumulative incidence was
11.7% for patients with 2 ? PDs and 7.7% for patients
with no PD (Fig. 2c).
Overall, 1568 out of 4339 (36.1%) patients who sur-
vived the hospitalization were readmitted within 90 days of
discharge of the patients (Table 3). The cumulative prob-
ability was 46.6% for patients with 2 ? PD and 28.8% for
patients with no PD. When comparing patients with
2 ? PDs with the other groups, patients with no PD (HR
0.53, CI99% 0.45–0.63), type 2 diabetes PD (HR 0.74,
CI99% 0.57–0.96) and cardiovascular PD (HR 0.71, CI99%
0.53–0.94) all had a lower risk of readmission (Fig. 2d).
Discussion
We have identified no other study that has questioned the
single disease focus when treating older patients by
exploring the prevalence and overlap of PDs in a large
population of older medical acutely hospitalized patients.
The major findings of this study are that (a) 19.4% of the
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patients had 2 ? PDs with overlaps appearing in 47 dif-
ferent combinations at a mostly low prevalence, the most
prevalent combination being type 2 diabetes and the car-
diovascular PD. However, 40.4% of the patients with this
combination had at least one more PD; (b) in total, 54.0%
were discharged directly from the ED. Patients with
2 ? PDs had a higher risk of both dying during hospital-
ization and dying after hospitalization than patients without
a PD. Patients with 2 ? PDs had a higher risk of read-
mission within 90 than patients with no PD, type 2 diabetes
PD and cardiovascular PD. No differences were seen for
readmission within 7 days; (c) patients with the cancer PD
had the lowest proportion of patients with 2 ? PDs, the
highest LOS, and higher risks of dying or being readmitted
within seven and 90 days.
In line with previous studies (Fortin et al. 2005;
Marengoni et al. 2009; van den Bussche et al. 2011;
Marengoni et al. 2011; Kirchberger et al. 2012), we found a
high prevalence of patients with more than one PD. Having
two or more PDs was frequent, with overlaps appearing in
many combinations with a mostly low prevalence. This
result is in agreement with other studies demonstrating a
similar prevalence of combinations of chronic conditions
despite a more extended list of chronic diseases (Maren-
goni et al. 2009; Kirchberger et al. 2012). The problem
with overlapping PDs is the complex treatment and self-
care follow-up regimes for hypothetical patients following
more than one clinical guideline, as illustrated by Boyd
et al. (Boyd et al. 2005) and Hughes et al. (2013). A recent
study has shown that one chronic disease can adversely
affect the management of another chronic disease and that
the physician together with the patient must weight the pros
and cons of several registered treatments (Søndergaard
et al. 2015). These results highlight the question of whether
or not DMPs should be constructed based on single dis-
eases. Furthermore, polypharmacy and drug interactions
are a major concern when following two or more DMPs
(Boyd et al. 2005; Hughes et al. 2013). Polypharmacy may
be necessary but is associated with severe adverse events
(Koper et al. 2013). In addition, the use of potentially
inappropriate medications is common among older persons
and associated with low functional capacity and low
health-related quality of life (Jensen et al. 2014). The dif-
ficulties in developing DMPs relevant to patients with
multimorbidity lie in part in the complexity of the different
recommendations for the medical treatment for the differ-
ent chronic diseases (Fabbri et al. 2012). Resolving these
difficulties requires knowledge about which chronic dis-
eases occur together so that the recommendations can take
into account possible drug interactions. Several studies
have examined patterns of multimorbidity and found
between three and five such patterns (Marengoni et al.
2009; Scha¨fer et al. 2010; Garcı´a-Olmos et al. 2012;
Kirchberger et al. 2012; Prados-Torres et al. 2012; Freund
et al. 2012). Knowledge and understanding of disease
patterns occurring in multimorbidity can provide
Fig. 1 Pecentage of patients having two or more program diseases
among patients with at least one program disease. Number of patients
with the program disease: diabetes type 2 (N = 804), COPD
(N = 920), cardiovascular (N = 751), Musculoskeletal (N = 297),
dementia (N = 636) and cancer (N = 449). COPD chronic obstruc-
tive pulmonary disease
Table 2 The four most
prevalent pairs of program
diseases among patients with
more than one program disease
(N = 904)
The four most prevalent pairs of
program diseases
Patients with one or more
additional PD
N % N %
1 Type 2 diabetes ? cardiovascular 203 22.5 82 40.4
2 COPD ? cardiovascular 164 18.1 82 50.0
3 Type 2 diabetes ? COPD 150 16.6 89 59.3
4 COPD ? dementia 137 15.1 68 49.6
COPD chronic obstructive pulmonary disease
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information that may support existing DMPs and new
DMPs for complex medical patients.
In this study, the most common combination among
patients with 2 ? PDs was the type 2 diabetes with the
cardiovascular PD, with a prevalence of 22.5%. The
association of type 2 diabetes and cardiovascular disease is
well known (Marks and Raskin 2000); thus, it would be
reasonable to suggest a DMP for patients who have both
conditions. Although we found that 40.4% of these patients
had at least one additional PD, this result indicates that
multimorbidity may consist of many disease combinations
in different patterns, supporting other international research
(Prados-Torres et al. 2014). To develop DMPs only for the
most prevalent pairs of PDs is therefore not a total solution.
Patients with 2 ? PDs had a high mortality risk and a
high risk of being acutely hospitalized 6 months prior to
the index admission and of being readmitted within
90 days from discharge. Several studies have found that
healthcare costs rise as patients develop more than one
chronic disease (Nagl et al. 2012; Foguet-Boreu et al. 2014;
Moffat and Mercer 2015; Palladino et al. 2016). Frag-
mented care based on treating single diseases in isolation
can lead to duplication of treatment (Barnett et al. 2012;
Salisbury 2012) and hence higher costs. Patients with
multimorbidity do differ; however, a study from The
Netherlands showed that the majority of patients with
multimorbidity did not have a higher level of healthcare
costs than patients with only on chronic disease, but that a
Fig. 2 Cumulative incidence plot of time to event for all-cause
mortality within 7 days of admission (a) and within 90 days from
discharge (b) and readmission within seven (c) and 90 days from
discharge (d) according to program disease. PD program disease,
COPD chronic obstructive pulmonary disease
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small group of patients with multimorbidity had a very
high level of costs (Hopman et al. 2015). These patients
were older, female, had low income and suffered from
more chronic diseases (Hopman et al. 2015).
Patients with the cancer PD had the highest median
LOS, high mortality and readmission rates within 7 and
90 days, and the lowest proportion of patients with
2 ? PDs compared to patients belonging to the other PDs,
resulting in a low degree of complexity. This result indi-
cates an advantage in keeping a single disease perspective
for older patients with cancer.
We found that 41.9% of the patients did not have a PD
and were therefore not eligible to enter a DMP. In this
group, 88.1% had been hospitalized or examined in out-
patient clinics with diseases in two or more ICD-10 disease
categories, possibly reflecting the burden and complexity
of the patient’ conditions and the degree of multimorbidity.
Furthermore, we found that patients without a PD had a
cumulative probability of 28.8% of being readmitted within
90 days, which was significantly lower than for patients
with a PD, though still relatively high. Despite this com-
plexity, patients without a PD had a LOS of only 1 day,
risking fragmented care. Hence, focusing on a few chron-
ical diseases does not solve the challenges for the older
medical patients. A solution could be to use measures of
frailty, which is found to be associated with an increased
risk of disability, hospitalization and long-term care (Clegg
et al. 2013), in combination with disease patterns as an
indicator of the need for care management. Frailty in
combination with disease patterns could help hospitals
communicate to the primary care sector about which
patients are in need of structured care to prevent hospital-
izations and readmissions.
A strength of this study is its population-based nature,
made possible by the Danish CPR number system, allow-
ing linkage at the individual level across nationwide and
local registries. We used a 10-year prevalence to define
whether a patient belonged to a PD, as recommended by
Schram et al. (2008). Furthermore, this study covered
patients both living at home and in care institutions.
Our study also has limitations. First, it is likely that the
registration of secondary diagnoses is focused on those
relevant for the specific hospital admission and thus does
not necessarily reflect all secondary diagnoses for the
patient. Furthermore, the diagnoses are based on routine
discharge registration and it cannot be excluded that
physicians differ with regard to coding quality possibly
introducing a risk of miscoding and undercoding. However,
a recent study by Thygesen et al. (2011) found that the
positive predictive value of ICD-10 codes used to assess
the Charlson comorbidity index score was 98% in the
Danish National Patient Register. By including ICD-10
codes from both hospitalizations and outpatient visits from
2002 to 2012, we have tried to increase the validity of the
diagnosis codes. Second, the method used for data collec-
tion in this study was register based. Schram et al. (2008)
found that the setting characteristics have an important
influence on the outcome of multimorbidity, with multi-
morbidity being more prevalent in a general practice set-
ting than in a hospital setting. Hence, the prevalence of
multimorbidity may be underestimated in this study. Third,
the inclusion of only one hospital may have reduced the
generalizability of the results, though Amager and Hvi-
dovre Hospital covers 10 different municipalities with
different socioeconomic levels, and we therefore believe
that the results are reasonably representative.
In conclusion, we found that overlaps of PDs defined by
the DMPs appeared in many combinations with mostly low
prevalence among acutely hospitalized older medical
patients. Patients with 2 ? PD had the highest risk of
readmission; however, patients without a PD still had a
cumulative risk of 28.8% for readmission within 90 days.
Hence, patients without a PD as well as patients with
2 ? PD are complex groups that could stand to benefit
from a more holistic approach in designing DMPs. How-
ever, for patients with cancer, keeping a single disease
perspective may be advantageous.
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